Niklaus G Schaefer

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. doi request reprint Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): value of 18F-FDG-PET/CT
    Niklaus G Schaefer
    Department of Internal Medicine, Clinic for Medical Oncology, University Hospital Zurich, Switzerland
    Eur J Radiol 81:e19-25. 2012
  2. ncbi request reprint Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Niklaus G Schaefer
    Division of Nuclear Medicine, Department of Radiology, University Hospital Zurich, Zurich, Switzerland
    Radiology 244:257-62. 2007
  3. ncbi request reprint Bone involvement in patients with lymphoma: the role of FDG-PET/CT
    Niklaus G Schaefer
    Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 34:60-7. 2007
  4. ncbi request reprint Potential use of humanized antibodies in the treatment of breast cancer
    Niklaus G Schaefer
    Medical Oncology, Department of Internal Medicine, University Hospital Zurich, Raemistr, 100, CH 8091 Zurich, Switzerland
    Expert Rev Anticancer Ther 6:1065-74. 2006
  5. doi request reprint Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT
    Patrick Veit-Haibach
    Department of Medical Radiology, Division of Nuclear Medicine, University Hospital Zuerich, Raemistrasse 100, 8091, Zuerich, Switzerland
    Abdom Imaging 35:528-36. 2010
  6. doi request reprint Combined PET/CT-perfusion in patients with head and neck cancers
    Patrick Veit-Haibach
    Department of Radiology, Division of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland
    Eur Radiol 23:163-73. 2013
  7. ncbi request reprint Changing PET/CT manifestation of neurolymphomatosis
    Klaus Strobel
    Division of Nuclear Medicine, University Hospital Zurich, Ramistrasse 100, 8091 Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 33:1244. 2006
  8. doi request reprint Influence of bowel preparation before 18F-FDG PET/CT on physiologic 18F-FDG activity in the intestine
    Jan D Soyka
    Department of Nuclear Medicine, University Hospital, Zurich, Switzerland
    J Nucl Med 51:507-10. 2010
  9. ncbi request reprint Pulmonary hypertrophic osteoarthropathy in a patient with nonsmall cell lung cancer: Diagnosis with FDG PET/CT
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Zurich, Switzerland
    Clin Nucl Med 31:624-6. 2006
  10. doi request reprint Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component
    Patrick Veit-Haibach
    Department of Medical Radiology, Division of Nuclear Medicine, University Hospital Zurich, Zuerich, Switzerland
    Eur Radiol 21:256-64. 2011

Detail Information

Publications17

  1. doi request reprint Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): value of 18F-FDG-PET/CT
    Niklaus G Schaefer
    Department of Internal Medicine, Clinic for Medical Oncology, University Hospital Zurich, Switzerland
    Eur J Radiol 81:e19-25. 2012
    ..To prospectively analyze different FDG-PET/CT-parameters (modified RECIST, SUVmax, TLG, PETvol) in patients with malignant pleural mesothelioma (MPM) under continued pemetrexed and platin based treatment...
  2. ncbi request reprint Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Niklaus G Schaefer
    Division of Nuclear Medicine, Department of Radiology, University Hospital Zurich, Zurich, Switzerland
    Radiology 244:257-62. 2007
    ....
  3. ncbi request reprint Bone involvement in patients with lymphoma: the role of FDG-PET/CT
    Niklaus G Schaefer
    Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 34:60-7. 2007
    ..To evaluate the diagnostic impact and clinical significance of FDG-avid bone lesions detected by FDG-PET/CT in patients with lymphoma...
  4. ncbi request reprint Potential use of humanized antibodies in the treatment of breast cancer
    Niklaus G Schaefer
    Medical Oncology, Department of Internal Medicine, University Hospital Zurich, Raemistr, 100, CH 8091 Zurich, Switzerland
    Expert Rev Anticancer Ther 6:1065-74. 2006
    ..Here, an overview of humanized antibodies in human breast cancer is provided, with emphasis on the recent advances and future prospects in treating malignant breast cancer...
  5. doi request reprint Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT
    Patrick Veit-Haibach
    Department of Medical Radiology, Division of Nuclear Medicine, University Hospital Zuerich, Raemistrasse 100, 8091, Zuerich, Switzerland
    Abdom Imaging 35:528-36. 2010
    ..To integrate CT-perfusion into a routine, clinical contrast-enhanced (ce) PET/CT protocol for the evaluation of liver metastases and to compare functional CT and PET parameters...
  6. doi request reprint Combined PET/CT-perfusion in patients with head and neck cancers
    Patrick Veit-Haibach
    Department of Radiology, Division of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland
    Eur Radiol 23:163-73. 2013
    ..The aim of the study was to investigate the relationship between FDG and CTP data in patients with head and neck cancers...
  7. ncbi request reprint Changing PET/CT manifestation of neurolymphomatosis
    Klaus Strobel
    Division of Nuclear Medicine, University Hospital Zurich, Ramistrasse 100, 8091 Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 33:1244. 2006
  8. doi request reprint Influence of bowel preparation before 18F-FDG PET/CT on physiologic 18F-FDG activity in the intestine
    Jan D Soyka
    Department of Nuclear Medicine, University Hospital, Zurich, Switzerland
    J Nucl Med 51:507-10. 2010
    ..Our objective was to investigate the use of bowel preparation before (18)F-FDG PET/CT to reduce intestinal (18)F-FDG uptake...
  9. ncbi request reprint Pulmonary hypertrophic osteoarthropathy in a patient with nonsmall cell lung cancer: Diagnosis with FDG PET/CT
    Klaus Strobel
    Division of Nuclear Medicine, Department of Medical Radiology, University Hospital Zurich, Zurich, Switzerland
    Clin Nucl Med 31:624-6. 2006
  10. doi request reprint Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component
    Patrick Veit-Haibach
    Department of Medical Radiology, Division of Nuclear Medicine, University Hospital Zurich, Zuerich, Switzerland
    Eur Radiol 21:256-64. 2011
    ..To assess the clinical value of multi-phase, contrast-enhanced DOPA-PET/CT with emphasis on the diagnostic CT component in patients with neuroendocrine tumours (NET)...
  11. doi request reprint Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad antibody responses in humans, a RAYS-based analysis
    Axel Mischo
    University Hospital Zurich, Department of Oncology, Ramistr 100, CH 8091 Zurich, Switzerland
    Int J Oncol 39:287-94. 2011
    ..We rarely found IgG2 and IgG4 subclass antibodies. Our results support the implication that target-specific antibodies raised after vaccination contribute to the stimulation of an effective T cell response against the target antigen...
  12. ncbi request reprint Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?
    Niklaus G Schaefer
    Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, CH 8091 Zurich, Switzerland
    Radiology 232:823-9. 2004
    ....
  13. doi request reprint Protocol requirements and diagnostic value of PET/MR imaging for liver metastasis detection
    Caecilia S Reiner
    Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 41:649-58. 2014
    ..To compare the accuracy of PET/MR imaging with that of FDG PET/CT and to determine the MR sequences necessary for the detection of liver metastasis using a trimodality PET/CT/MR set-up...
  14. doi request reprint Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer
    Jan D Soyka
    Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland
    Eur J Nucl Med Mol Imaging 39:936-43. 2012
    ..To investigate the clinical value of (18)F-fluorocholine PET/CT (CH-PET/CT) in treatment decisions in patients with recurrent prostate cancer (rPCA)...
  15. ncbi request reprint Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP
    Panagiotis Samaras
    Department of Oncology, University Hospital Zurich, Switzerland
    Ann Hematol 89:783-7. 2010
    ..068). Concomitant statin use had no adverse impact on response to chemotherapy, EFS, and OS in patients treated with R-CHOP for DLBCL...
  16. doi request reprint Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine
    Irene A Burger
    Division of Nuclear Medicine, Department Medical Radiology, University Hospital of Zurich, Zurich, Switzerland
    Clin Nucl Med 36:848-53. 2011
    ..To analyze the effect of H1N1 influenza A virus vaccination in patients referred for staging or follow-up F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) for different malignant tumors...
  17. doi request reprint Tumor imaging in patients with advanced tumors using a new (99m) Tc-radiolabeled vitamin B12 derivative
    Bert Ram Sah
    Division of Nuclear Medicine, Department Medical Radiology, University Hospital of Zurich, Zurich, Switzerland
    J Nucl Med 55:43-9. 2014
    ..In this prospective study, we investigated cancer-specific uptake of (99m)Tc-PAMA-cobalamin in 10 patients with various metastatic tumors...